{
  "meta": {
    "title": "Miscellaneous",
    "url": "https://brainandscalpel.vercel.app/miscellaneous-ce20be11.html",
    "scrapedAt": "2025-12-01T04:08:31.883Z"
  },
  "questions": [
    {
      "text": "<p>A 36-year-old man comes to the office due to chronic, mild dyspnea and fatigue.&nbsp; The patient also says that his mind seems &#x22;foggy&#x22; all the time and he is not able to think clearly.&nbsp; He has no significant past medical history and does not take any medication.&nbsp; He lives a sedentary lifestyle and has smoked a half-pack of cigarettes a day for 5 years.&nbsp; Blood pressure is 140/85 mm Hg, pulse is 84/min, and respirations are 18/min.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Lung auscultation is unremarkable.&nbsp; Chest x-ray is normal.&nbsp; Arterial blood gas analysis shows partial pressure of oxygen (PaO<font size=\"2\"><sub>2</sub></font>) is 66 mm Hg and partial pressure of carbon dioxide (PaCO<font size=\"2\"><sub>2</sub></font>) is 58 mm Hg.&nbsp; His estimated alveolar to arterial oxygen gradient is 10 mm Hg.&nbsp; Which of the following best explains this patient&#39;s laboratory findings?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Chronic hypoventilation"
        },
        {
          "id": 2,
          "text": "Decreased lung diffusing capacity"
        },
        {
          "id": 3,
          "text": "Destruction of lung parenchyma"
        },
        {
          "id": 4,
          "text": "Increased lung compliance"
        },
        {
          "id": 5,
          "text": "Increased tissue oxygen consumption"
        },
        {
          "id": 6,
          "text": "Right-to-left shunt"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Physiology > Pulmonary & Critical Care > Obesity hypoventilation syndrome</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><div id=\"div_T50750\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Causes of hypoxemia</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Examples</strong></p></td><td><p align=\"center\"><strong>A-a gradient</strong></p></td></tr><tr><td><p align=\"center\"><strong>Reduced PiO<sub>2</sub></strong></p></td><td><p align=\"center\">High altitude</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td><p align=\"center\"><strong>Hypoventilation</strong></p></td><td><p align=\"center\">CNS depression, morbid obesity</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td><p align=\"center\"><strong>Diffusion limitation</strong></p></td><td><p align=\"center\">Emphysema, ILD</p></td><td><p align=\"center\">Increased</p></td></tr><tr><td><p align=\"center\"><strong>V/Q mismatch*</strong></p></td><td><p align=\"center\">Pulmonary embolism, pneumonia</p></td><td><p align=\"center\">Increased</p></td></tr><tr><td colspan=\"3\"><p><strong>*</strong>Caused by regional dead-space ventilation and/or intrapulmonary shunting.</p><p><strong>A-a gradient</strong> = alveolar to arterial oxygen gradient; <strong>ILD</strong> = interstitial lung disease; <strong>PiO<sub>2</sub></strong> = partial pressure of inspired oxygen; <strong>V/Q</strong> = ventilation/perfusion ratio.</p></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div><p>This patient with chronic fatigue, dyspnea, difficulty concentrating, <strong>hypoxemia</strong> (PaO<font size=\"2\"><sub>2</sub></font> &lt;75 mm Hg), and <strong>hypercapnia</strong> (PaCO<font size=\"2\"><sub>2</sub></font> &gt;45 mm Hg) in the setting of <strong>obesity</strong> (BMI &gt;30 kg/m<font size=\"2\"><sup>2</sup></font>) likely has <strong>obesity hypoventilation syndrome</strong> (OHS).&nbsp; OHS results from physical restriction of lung expansion by excessive thoracic tissue mass.&nbsp; As such, the hypoventilation mostly results from <strong>reduced tidal volume</strong> and patients may have normal or increased respiratory rate.&nbsp; Most patients with OHS also have concomitant obstructive sleep apnea (OSA); unlike isolated OSA that involves hypoventilation only with sleep, OHS involves hypoventilation throughout the waking hours.</p><p>In healthy individuals, a normal alveolar to arterial (A-a) gradient ranges from 4-15 mm Hg, with older individuals having a gradient towards the higher end of normal.&nbsp; A <strong>normal A-a gradient</strong> indicates that the efficiency of gas exchange between the alveoli and the blood is intact; therefore, hypoxemia must result from low partial pressure of alveolar oxygen (PAO<font size=\"2\"><sub>2</sub></font>).&nbsp; Low PAO<font size=\"2\"><sub>2</sub></font> can occur due to <strong>alveolar hypoventilation</strong> (eg, OHS, neuromuscular disease, central depression of respiratory drive) or inspiration of low partial pressure of oxygen at high altitude.</p><p><strong>(Choices B and C)</strong>&nbsp; Destruction of lung parenchyma occurs with both emphysema and interstitial lung disease.&nbsp; This leads to disruption of the alveolar-capillary membrane and impaired diffusion capacity with an increased A-a gradient.&nbsp; In OHS, the lung parenchyma is undamaged and diffusion capacity is intact.</p><p><strong>(Choice D)</strong>&nbsp; Although the lung parenchyma is unaffected in OHS, restricted expansion of the chest wall secondarily restricts lung expansion, effectively decreasing lung compliance.</p><p><strong>(Choice E)</strong>&nbsp; Tissue oxygen consumption does increase with increased body mass, but it is a relatively minor factor and would not cause hypoxemia or hypercapnia in the absence of hypoventilation.</p><p><strong>(Choice F)</strong>&nbsp; Right-to-left shunting (eg, Eisenmenger syndrome) results in hypoxemia with an elevated A-a gradient because a large percentage of cardiac output bypasses the alveolar capillaries and does not undergo gas exchange.</p><p><strong>Educational objective:</strong><br>Obesity hypoventilation syndrome commonly presents with chronic fatigue, dyspnea, and difficulty concentrating.&nbsp; Patients will have BMI &gt;30 kg/m<font size=\"2\"><sup>2</sup></font> and arterial blood gas while awake showing evidence of hypoventilation, including hypercapnia (PaCO<font size=\"2\"><sub>2</sub></font> &gt;45 mm Hg) and usually hypoxemia (PaO<font size=\"2\"><sub>2</sub></font> &lt;75 mm Hg).&nbsp; The expected alveolar to arterial oxygen gradient is normal (4-15 mm Hg) with hypoventilation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "1526",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 34-year-old man is hospitalized due to trauma sustained during a motor vehicle collision.&nbsp; He subsequently develops worsening shortness of breath and confusion and dies despite appropriate management.&nbsp; Autopsy examination shows scattered petechiae on the anterior thorax.&nbsp; Microscopic evaluation of his pulmonary vessels reveals the findings shown below.</p><p><img draggable=\"false\" id=\"18478\" src=\"https://www.uworld.com/media/U4638.jpg\" ></p><p>Which of the following most likely predisposed this patient to developing the observed histopathologic abnormality?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Aspiration of gastric contents"
        },
        {
          "id": 2,
          "text": "Left ventricular dysfunction"
        },
        {
          "id": 3,
          "text": "Long-bone fracture"
        },
        {
          "id": 4,
          "text": "Severe systemic infection"
        },
        {
          "id": 5,
          "text": "Thrombosis in the deep veins"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathology > Pulmonary & Critical Care > Fat embolism</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img draggable=\"false\" id=\"18475\" src=\"https://www.uworld.com/media/L43449.jpg\" ></p><p>The histologic section of this patient&#39;s lung shows an aggregate of fat globules, hematopoietic cells, and organizing thrombus lodged inside the pulmonary vasculature.&nbsp; This is consistent with bone marrow embolism, which occurs in <strong>fat embolism syndrome</strong> (FES).</p><p>FES classically presents with the triad of <strong>respiratory distress</strong>, <strong>neurologic impairment</strong>, and <strong>petechial rash</strong> within <strong>24-72 hours</strong> following a <strong>long-bone or pelvic fracture</strong>.&nbsp; Severe skeletal injuries can cause fat globules to be dislodged from bone marrow into the bloodstream, where they form aggregates with platelets and red blood cells.&nbsp; These aggregates occlude pulmonary microvessels and impair gas exchange.&nbsp; Some fat emboli may be small enough to pass through the pulmonary circulation and cause microvascular occlusion in the systemic circulation, leading to the neurologic manifestations (eg, confusion) and petechial rash characterizing the condition.&nbsp; Release of toxic inflammatory mediators (eg, cytokines, free fatty acids) may also contribute to the neurologic manifestations and rash.&nbsp; Thrombocytopenia can occur due to platelet adherence and aggregation to circulating fat globules.</p><p><strong>(Choice A)</strong>&nbsp; Aspiration of gastric contents can lead to aspiration pneumonitis or aspiration pneumonia.&nbsp; The lung parenchyma would demonstrate polymorphonuclear leukocyte&nbsp;infiltration and multinucleated foreign body giant cells.</p><p><strong>(Choice B)</strong>&nbsp; Left ventricular dysfunction can lead to heart failure and pulmonary edema.&nbsp; Over time, alveolar fibrosis develops and there is accumulation of <a href=\"42066\">hemosiderin-laden macrophages</a>, also known as heart failure cells.</p><p><strong>(Choice D)</strong>&nbsp; Severe systemic infection, or sepsis, can lead to acute respiratory distress syndrome, in which parenchymal inflammation leads to accumulation of interstitial fluid and fluid leakage in the alveoli.&nbsp; Histopathology often shows <a href=\"42819\">diffuse alveolar damage</a>.</p><p><strong>(Choice E)</strong>&nbsp; Thrombosis in the deep veins can lead to acute <a href=\"45585\">pulmonary embolism</a>.&nbsp; Due to localized ischemia, the adjacent lung parenchyma can demonstrate coagulative necrosis and hemorrhage.</p><p><strong>Educational objective:</strong><br>Fat embolism syndrome most commonly results from the release of fat globules from bone marrow following a long-bone or pelvic fracture.&nbsp; The fat globules form inflammatory aggregates that cause microvessel obstruction and systemic inflammation leading to the triad of respiratory distress, neurologic dysfunction, and petechial rash.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "197",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 62-year-old woman is brought to the emergency department due to progressive weakness and dyspnea.&nbsp; The patient is visiting her niece, who says the patient forgot to bring her regular medications and has not been taking them for the past week.&nbsp; The patient began feeling weak and fatigued 3 days ago and has had shortness of breath since yesterday.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 122/88 mm Hg, pulse is 90/min, and respirations are 24/min and shallow.&nbsp; On physical examination, the patient appears dyspneic with drooping at the eyelids and corners of the mouth.&nbsp; Her speech has a nasal quality.&nbsp; Arterial blood gas obtained on room air shows pH 7.32; PaCO<font size=\"2\"><sub>2</sub></font> is 52 mm Hg, PaO<font size=\"2\"><sub>2</sub></font> is 72 mm Hg, and HCO<font size=\"2\"><sub>3</sub></font> is 26 mEq/L.&nbsp; Bedside spirometry demonstrates decreased forced vital capacity.&nbsp; A pathologic process involving which of the following structures is the most likely cause of this patient&#39;s shortness of breath?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Brain stem respiratory center"
        },
        {
          "id": 2,
          "text": "Muscles of respiration"
        },
        {
          "id": 3,
          "text": "Pulmonary arteries"
        },
        {
          "id": 4,
          "text": "Terminal airways and alveoli"
        },
        {
          "id": 5,
          "text": "Upper larger airways"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathophysiology > Pulmonary & Critical Care > Myasthenia gravis</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img draggable=\"false\" id=\"14506\" src=\"https://www.uworld.com/media/L39119.jpg\" ></p><p>This patient has hypercapnic and hypoxic respiratory failure (low pH, high CO<font size=\"2\"><sub>2</sub></font>, low O<font size=\"2\"><sub>2</sub></font>) indicating <strong>global hypoventilation</strong>.&nbsp; In association with the ptosis, bulbar weakness, and low forced vital capacity, this presentation suggests <strong>myasthenic crisis</strong> (severe weakness and respiratory depression due to an exacerbation of myasthenia gravis [MG]).</p><p>MG is characterized by <strong>autoantibodies against nicotinic acetylcholine receptors</strong> on the postsynaptic membrane of the neuromuscular junction, resulting in receptor degradation.&nbsp; This reduces the sensitivity of the postsynaptic membrane to acetylcholine stimulation, leading to reduced muscular response despite normal acetylcholine release.&nbsp; Muscle <strong>weakness worsens with repetition</strong> as acetylcholine stores within the presynaptic nerve terminal become progressively depleted.</p><p>Patients with MG typically have extraocular (eg, ptosis, diplopia), bulbar (eg, dysphonia, difficulty chewing), and facial (eg, myasthenic snarl) weakness.&nbsp; In addition, neck and proximal muscle weakness may occur, and in severe cases the <strong>respiratory muscles</strong> may be affected, leading to <strong>respiratory failure</strong> (as in this patient).&nbsp; Acetylcholinesterase inhibitors (eg, pyridostigmine, neostigmine) are used for symptomatic treatment, and withdrawal can trigger a myasthenic crisis.</p><p><strong>(Choice A)</strong>&nbsp; Impairment of the respiratory control centers in the brain stem causes hypoventilation during sleep (Ondine curse); however, voluntary breathing is unaffected.</p><p><strong>(Choice C)</strong>&nbsp; Pulmonary embolism can result in dyspnea and gas exchange abnormalities (eg, hypoxia).&nbsp; However, significant muscular weakness (eg, ptosis, nasal speech, decreased vital capacity) would be unexpected.</p><p><strong>(Choices D and E)</strong>&nbsp; Patients with diseases involving the terminal airways and alveoli (eg, pulmonary fibrosis, emphysema) and large airways (eg, asthma, chronic bronchitis) can present with respiratory failure subsequent to muscle fatigue.&nbsp; However, these diseases are not associated with non-respiratory muscle weakness (eg, dysphonia, bulbar weakness).</p><p><strong>Educational objective:</strong><br>Myasthenia gravis is characterized by autoantibodies against postsynaptic nicotinic acetylcholine receptors at the neuromuscular junction, which result in receptor degradation.&nbsp; Patients typically have extraocular, bulbar, and facial weakness that worsens with activity.&nbsp; In severe cases, the respiratory muscles may be affected, leading to hypoventilation and respiratory failure.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "14203",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 68-year-old man is evaluated in the hospital due to a pleural effusion.&nbsp; He has a history of base of tongue squamous cell carcinoma with involvement of multiple left anterior cervical lymph nodes.&nbsp; Two days ago, the patient underwent surgery to remove the tumor and the anterior cervical lymph nodes.&nbsp; Today, he has increasing shortness of breath, and chest x-ray reveals a large left pleural effusion.&nbsp; Which of the following was most likely injured during this patient&#39;s surgical procedure?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Esophagus"
        },
        {
          "id": 2,
          "text": "Innominate artery"
        },
        {
          "id": 3,
          "text": "Lung parenchyma"
        },
        {
          "id": 4,
          "text": "Phrenic nerve"
        },
        {
          "id": 5,
          "text": "Thoracic duct"
        },
        {
          "id": 6,
          "text": "Trachea"
        }
      ],
      "correct_choice_id": 5,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Anatomy > Pulmonary & Critical Care > Pleural effusion</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img draggable=\"false\" id=\"34453\" src=\"https://www.uworld.com/media/L60343.jpg\" ></p><p>This patient with a pleural effusion 2 days after cervical lymph node removal most likely has a <strong>chylothorax</strong> due to intraoperative injury of the <strong>thoracic duct</strong>.</p><p>The thoracic duct is the largest lymphatic vessel.&nbsp; It originates at about the level of T12 in the abdomen where the lumbar and intestinal lymph trunks converge.&nbsp; It travels superiorly through the mediastinum (posterior to the esophagus) and drains into the <strong>junction between the left subclavian and jugular veins</strong> in the lower neck.&nbsp; It is most commonly injured during <strong>thoracic procedures</strong> (eg, esophagectomy) but can be injured in neck procedures as well (eg, cervical lymph node removal).&nbsp; Injury can result in leakage of lymph into either the neck or the thorax because a transected duct may retract into the chest.</p><p>The thoracic duct collects lymph from most of the body, including the abdominal viscera, the viscera of the left hemithorax, all tissue inferior to the umbilicus, and all left-sided tissues superior to the umbilicus (the right head, arm, and thorax drain into the much smaller right lymphatic duct).</p><p><strong>(Choices A and F)</strong>&nbsp; The trachea and esophagus are deeper structures in the central neck that are covered by strap muscles; they are unlikely to be injured during removal of cervical lymph nodes in the lateral neck.&nbsp; In addition, although injury to the esophagus or trachea can cause pleural effusion, such injury is typically accompanied by air accumulation (eg, crepitus in the neck and/or pneumomediastinum).</p><p><strong>(Choice B)</strong>&nbsp; The innominate artery is the first branch of the aortic arch, and it crosses the midtrachea from left to right (in the thorax).&nbsp; It does not travel through the left neck.&nbsp; In addition, injury to the innominate artery would cause massive blood loss, resulting in immediate hemodynamic instability.</p><p><strong>(Choice C)</strong>&nbsp; The apex of the lung can project into the neck and be injured in some neck surgical procedures.&nbsp; However, injury would cause an acute pneumothorax rather than a slowly accumulating pleural effusion.</p><p><strong>(Choice D)</strong>&nbsp; The phrenic nerve, which originates from C3-C5 and travels with the internal jugular vein, can be injured during neck procedures.&nbsp; However, such an injury would present with elevation of the hemidiaphragm.</p><p><strong>Educational objective:</strong><br>The thoracic duct carries lymph from most of the body and drains into the junction between the left subclavian and jugular veins.&nbsp; Although most commonly injured in thoracic procedures, it can also be injured in neck procedures where it travels through the neck.&nbsp; Injury may result in a chylothorax.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "17204",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 63-year-old man with a history of chronic obstructive pulmonary disease comes to the office for a follow-up visit.&nbsp; He uses a tiotropium inhaler daily, and his pulmonary symptoms are sufficiently controlled.&nbsp; During a previous visit, the patient was counseled on the benefits of smoking cessation.&nbsp; He reports that despite trying he has been unable to stop smoking due to overwhelming cravings.&nbsp; The physician prescribes a drug that reduces nicotine cravings and decreases the pleasurable effects of cigarettes and other tobacco products.&nbsp; Which of the following medications was most likely prescribed to the patient?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Clonazepam"
        },
        {
          "id": 2,
          "text": "Fluoxetine"
        },
        {
          "id": 3,
          "text": "Nicotine patch"
        },
        {
          "id": 4,
          "text": "Topiramate"
        },
        {
          "id": 5,
          "text": "Varenicline"
        }
      ],
      "correct_choice_id": 5,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pharmacology > Pulmonary & Critical Care > Smoking Cessation</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img  draggable=\"false\" id=\"7915\" src=\"https://www.uworld.com/media/highresdefault/L11554.jpg\"  ></p><p>Quitting smoking cigarettes is difficult due to nicotine content and its activation of reward pathways in the brain.&nbsp; The reinforcing effects of nicotine that lead to dependence are thought to be caused by stimulation of the alpha-4 beta-2<strong> nicotinic acetylcholine receptor</strong> present in the CNS.&nbsp; <strong>Varenicline</strong> is a <strong>partial agonist</strong> of this receptor that competes with nicotine (a full agonist) and prevents it from binding to the receptor.</p><p>Because varenicline is a partial agonist, it helps <strong>reduce</strong> the symptoms of <strong>nicotine withdrawal</strong> by mildly stimulating the receptor.&nbsp; However, because varenicline is not a full agonist, downstream release of dopamine is modest, resulting in <strong>less stimulation of reward pathways</strong> than nicotine.</p><p><strong>(Choices A and B)</strong>&nbsp; Benzodiazepines (eg, clonazepam) and selective serotonin reuptake inhibitors (eg, fluoxetine) have not been shown to be effective for smoking cessation.</p><p><strong>(Choice C)</strong>&nbsp; Nicotine patches slowly release nicotine, thus preventing withdrawal symptoms when the patient stops using cigarettes.&nbsp; However, because nicotine is a full agonist (and does not partially block the receptor like varenicline does), patches do not prevent the pleasurable effects of additional nicotine received by smoking cigarettes.</p><p><strong>(Choice D)</strong>&nbsp; Topiramate is an anticonvulsant used to treat epilepsy, and it is also effective for migraine prophylaxis.&nbsp; Several studies have tested the effectiveness of topiramate for smoking cessation; however, the current evidence shows little or no significant difference in long-term tobacco abstinence over placebo.</p><p><strong>Educational objective:</strong><br>Varenicline is a partial agonist of nicotinic acetylcholine receptors.&nbsp; It can help patients stop using tobacco by reducing withdrawal symptoms and attenuating the rewarding effects of nicotine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "8748",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 64-year-old man comes to the office due to worsening dyspnea on exertion for the past 3 months.&nbsp; The patient has had a nonproductive cough but no chest pain, fever, or chills.&nbsp; He was diagnosed with hypertension several years ago but takes no medications.&nbsp; Blood pressure is 160/96 mm Hg, pulse is 92/min, and respirations are 18/min.&nbsp; Physical examination shows bilateral inspiratory crackles as well as dullness to percussion and decreased breath sounds at the right lung base.&nbsp; Chest x-ray reveals a right-sided pleural effusion.&nbsp; Which of the following pleuropulmonary changes are most likely present in this patient?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Increased\n\t\t\t\n\t\t\t\n\t\t\t\tNormal\n\t\t\t\n\t\t\t\n\t\t\t\tNormal\n\t\t\t\n\t\t\t\n\t\t\t\tDecreased"
        },
        {
          "id": 2,
          "text": "Increased\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased\n\t\t\t\n\t\t\t\n\t\t\t\tDecreased\n\t\t\t\n\t\t\t\n\t\t\t\tDecreased"
        },
        {
          "id": 3,
          "text": "Normal\n\t\t\t\n\t\t\t\n\t\t\t\tNormal\n\t\t\t\n\t\t\t\n\t\t\t\tDecreased\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased"
        },
        {
          "id": 4,
          "text": "Normal\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased\n\t\t\t\n\t\t\t\n\t\t\t\tNormal\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased"
        },
        {
          "id": 5,
          "text": "Decreased\n\t\t\t\n\t\t\t\n\t\t\t\tDecreased\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Physiology > Pulmonary & Critical Care > Pleural effusion</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img draggable=\"false\" id=\"22505\" src=\"https://www.uworld.com/media/L48965.jpg\" ></p><p>In the normal state, the pleural space contains a small amount of fluid (eg, 5-10 mL) that undergoes constant turnover, with the rate of inflow equivalent to the rate of outflow.&nbsp; The <strong>rate of inflow</strong> is determined by vascular <strong>hydrostatic pressure</strong>, vascular <strong>oncotic pressure</strong>, and vascular <strong>membrane permeability</strong> (ie, the <a href=\"16909\">Starling equation</a>), whereas the <strong>rate of outflow</strong> is determined by the drainage capacity of the <strong>parietal pleural lymphatics</strong>.&nbsp; A <strong>pleural effusion</strong> results from an increased rate of pleural fluid inflow, a decreased rate of pleural fluid outflow, or a combination of the two.</p><p>This patient with progressive dyspnea on exertion, nonproductive cough, bilateral crackles on lung auscultation, and a right-sided pleural effusion most likely has <strong>decompensated heart failure</strong> (chronic, poorly controlled hypertension is a common cause).&nbsp; Pleural effusion in decompensated heart failure is primarily driven by backward transmission of pressure from the failing left ventricle to the pulmonary circulation, resulting in <strong>increased pulmonary capillary hydrostatic pressure</strong> and an increased rate of fluid inflow to the pleural space.&nbsp; Vascular permeability remains normal, as does vascular oncotic pressure (which is mostly determined by serum albumin concentration).&nbsp; Outflow through the parietal pleural lymphatics increases in response to the increased fluid inflow, but it is unable to keep up, resulting in development of pleural effusion.</p><p><strong>(Choice A)</strong>&nbsp; Lung malignancy can cause pleural effusion via both an increased rate of inflow due to an inflammatory increase in vascular membrane permeability and a decreased rate of outflow due to obstruction of parietal pleural lymphatics.</p><p><strong>(Choice B)</strong>&nbsp; All 4 of these changes encourage the development of pleural effusion and multiple disturbances would be required for such changes to take place (eg, lung malignancy [increased vascular permeability and decreased lymphatic flow] in the setting of both hypoalbuminemia [decreased oncotic pressure] and heart failure [increased hydrostatic pressure]).</p><p><strong>(Choice C)</strong>&nbsp; Hypoalbuminemia (eg, due to nephrotic syndrome or malnutrition) causes pleural effusion due to an increased rate of pleural fluid inflow from reduced vascular oncotic pressure.&nbsp; As with decompensated heart failure, lymphatic flow increases but is unable to keep up with the increased inflow.</p><p><strong>(Choice E)</strong>&nbsp; All 4 of these changes would discourage the development of pleural effusion.</p><p><strong>Educational objective:</strong><br>Pleural effusion results from an increased rate of fluid inflow from the nearby vasculature or a decreased rate of fluid outflow through the parietal pleural lymphatics.&nbsp; Decompensated heart failure causes pleural effusion primarily due to increased fluid inflow from increased pulmonary capillary hydrostatic pressure; lymphatic outflow increases but is unable to keep up with the increased inflow.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "18698",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 52-year-old woman with a history of cirrhosis due to chronic hepatitis C experiences worsening dyspnea.&nbsp; She has no other medical conditions.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows normal jugular venous pressure, right-sided dullness to percussion and decreased breath sounds, normal heart sounds, and moderate-sized ascites.&nbsp; Chest x-ray reveals a large right-sided pleural effusion with no parenchymal lesions.&nbsp; Thoracentesis yields transudative fluid with normal cell counts.&nbsp; Which of the following is the most likely underlying mechanism of this patient&#39;s pulmonary findings?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Fluid movement across the diaphragm"
        },
        {
          "id": 2,
          "text": "Inflammatory disruption of pleural mesothelium"
        },
        {
          "id": 3,
          "text": "Malignant obstruction of pleural lymphatic drainage"
        },
        {
          "id": 4,
          "text": "Mechanical disruption of thoracic lymphatic flow"
        },
        {
          "id": 5,
          "text": "Rapid decrease in intrapleural pressure"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathophysiology > Pulmonary & Critical Care > Pleural effusion</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p>This patient with <strong>cirrhosis</strong> complicated by ascites who presents with a right-sided, transudative pleural effusion most likely has a <strong>hepatic hydrothorax</strong>.&nbsp; As ascites fluid accumulates in the abdomen, <strong>increased intraabdominal pressure</strong> can force fluid into the chest cavity through small fenestrations in the diaphragm; <strong>fluid movement across the diaphragm</strong> occurs most often on the <strong>right side</strong>.</p><p>Because the development of ascites in patients with cirrhosis is driven by changes in hydrostatic and oncotic pressure (ie, increased hydrostatic pressure due to portal venous hypertension and decreased oncotic pressure due to hypoalbuminemia), the pleural fluid in hepatic hydrothorax is <strong>transudative</strong> by <a href=\"18479\">Light criteria</a>.</p><p><strong>(Choice B)</strong>&nbsp; Inflammatory disruption of the visceral pleural mesothelium can occur in pneumonia, allowing bacteria in the alveoli to translocate into the pleural space and cause a complicated parapneumonic effusion.&nbsp; Parapneumonic effusions and other pleural effusions resulting from an inflammatory disruption of membrane permeability (eg, rheumatologic effusions, most malignant effusions) are exudative by Light criteria and usually have elevated leukocyte count.</p><p><strong>(Choice C)</strong>&nbsp; Malignant cells that have metastasized to the pleural space can cause pleural effusion by obstructing pleural fluid drainage via parietal pleura lymphatics.&nbsp; Liver cirrhosis predisposes to the development of hepatocellular carcinoma, which could metastasize to the pleural space; however, malignant effusions typically have high lymphocyte count and cytology frequently reveals malignant cells.</p><p><strong>(Choice D)</strong>&nbsp; Mechanical disruption of thoracic lymphatic flow (eg, injury to the thoracic duct) can cause a chylothorax, which is a milky white pleural effusion with very high triglyceride content.&nbsp; Chylothorax is usually exudative by Light criteria.</p><p><strong>(Choice E)</strong>&nbsp; Atelectasis causes a rapid decrease in intrapleural pressure (as alveoli collapse and pull farther away from the chest wall), and the pressure gradient created between the pleural space and the lung may drive the movement of interstitial fluid into the pleural space, causing a transudative pleural effusion.&nbsp; Pleural effusions due to atelectasis are usually relatively small; hepatic hydrothorax is more likely in this patient with a large, right-sided pleural effusion and a history of cirrhosis.</p><p><strong>Educational objective:</strong><br>Patients with cirrhosis complicated by abdominal ascites may develop a hepatic hydrothorax, which is a transudative, usually right-sided pleural effusion that results from passage of intraabdominal fluid into the chest cavity through small fenestrations in the diaphragm.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "18699",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 2-week-old girl is brought to the office for a weight check.&nbsp; She was born at 36 weeks gestation due to preterm labor.&nbsp; The patient has been gaining weight appropriately, and her parents have no concerns.&nbsp; When questioned about the home environment, the mother says that she started smoking cigarettes after delivery due to the stress of sleep deprivation.&nbsp; The mother did not smoke during pregnancy, and the father is a nonsmoker.&nbsp; Support is provided, and the mother is counseled regarding the risks of secondhand smoke exposure.&nbsp; Which of the following conditions is the patient at increased risk for developing due to this exposure?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Apnea of prematurity"
        },
        {
          "id": 2,
          "text": "Epilepsy"
        },
        {
          "id": 3,
          "text": "Failure to thrive"
        },
        {
          "id": 4,
          "text": "Sudden infant death syndrome"
        },
        {
          "id": 5,
          "text": "Ventricular arrhythmia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathology > Pulmonary & Critical Care > SIDS</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><div id=\"div_T62414\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Risks of secondhand smoke exposure in children</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risks</strong></p></td><td><p align=\"center\"><strong>Pathophysiology</strong></p></td></tr><tr><td><p align=\"center\"><strong>Respiratory disease<br>(eg, pneumonia, asthma)</strong></p></td><td><ul><li>Impaired mucociliary clearance of respiratory tract</li><li>Impaired phagocytosis by alveolar macrophages</li><li>Immune &amp; inflammatory cell recruitment to lung tissue</li></ul></td></tr><tr><td><p align=\"center\"><strong>Recurrent otitis media</strong></p></td><td><ul><li>Impaired mucociliary clearance of eustachian tube</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prematurity &amp;<br>low birth weight</strong></p></td><td><ul><li>Transplacental exposure to components of tobacco smoke</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sudden infant<br>death syndrome</strong></p></td><td><ul><li>Likely related to impaired arousal &amp; cardiovascular responses to stimuli</li></ul></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div><p><strong>Secondhand smoke</strong> (SHS) exposure can adversely affect nearly every organ system, most notably the respiratory tract (eg, pneumonia, asthma).&nbsp; One of the most serious effects of SHS exposure is the increased risk for <strong>sudden infant death syndrome (SIDS)</strong>.</p><p>SIDS refers to the unexpected death of a previously healthy infant with an inconclusive postmortem examination.&nbsp; Almost all cases are associated with at least 1 risk factor, such as prematurity, an unsafe sleep environment, and smoke exposure.&nbsp; Smoke exposure likely contributes to SIDS by causing <strong>impaired arousal</strong> and cardiovascular response&nbsp;to stimuli (eg, hypoxemia).</p><p>The risk of SIDS is further increased in cases of <strong>maternal cigarette use during pregnancy</strong>, which is associated with impaired fetal oxygenation and direct exposure of the fetus to toxins (eg, nicotine, carbon monoxide).&nbsp; The degree of risk correlates with the amount of cigarette use, suggesting a dose-response relationship between smoking and SIDS.</p><p><strong>(Choice A)</strong>&nbsp; Because maternal smoking during pregnancy (not seen here)&nbsp;increases the risk of preterm delivery, the risk of prematurity-associated complications (eg, apnea of prematurity) is also increased.&nbsp; However, these risks do not increase with postnatal SHS exposure.&nbsp; Moreover, apnea of prematurity typically presents with apneic episodes in the first 2-3 days of life.</p><p><strong>(Choice B)</strong>&nbsp; SHS increases the risk for respiratory tract disease and recurrent otitis media in children; parents who smoke outside the home should be counseled on cessation because chemicals from cigarette smoke are adsorbed and retained by clothing, skin, and hair and therefore still pose a risk to children.&nbsp; SHS is not associated with an increased risk for epilepsy.</p><p><strong>(Choice C)</strong>&nbsp; SHS does not increase the risk for failure to thrive in infancy.&nbsp; In fact, SHS may be associated with childhood obesity.</p><p><strong>(Choice E)</strong>&nbsp; SHS exposure in childhood increases the risk for atrial fibrillation in adulthood but is not associated with ventricular arrhythmias.</p><p><strong>Educational objective:</strong><br>Maternal tobacco use during pregnancy and secondhand smoke exposure are associated with an increased risk for sudden infant death syndrome (SIDS).&nbsp; Pathophysiology of the association between smoke exposure and SIDS may relate to impaired arousal and cardiovascular response&nbsp;to stimuli (eg, airflow obstruction).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "310",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 24-year-old previously healthy man is brought to the emergency department after a motor vehicle collision in which he sustained trauma to the left side of the chest and the abdomen.&nbsp; On arrival, the patient is hypotensive and tachycardic.&nbsp; Evaluation reveals left-sided rib fractures and hemoperitoneum due to splenic laceration.&nbsp; Urgent exploratory laparotomy under general anesthesia is planned.&nbsp; In the operating room, etomidate is administered for rapid sequence induction.&nbsp; Which of the following characteristics best describes etomidate as compared to propofol?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Analgesic effect in addition to sedation"
        },
        {
          "id": 2,
          "text": "Higher risk of lipid abnormalities"
        },
        {
          "id": 3,
          "text": "Lower risk of adrenocortical suppression"
        },
        {
          "id": 4,
          "text": "No cardiovascular depressant effect"
        },
        {
          "id": 5,
          "text": "Possible use for maintenance anesthesia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pharmacology > Pulmonary & Critical Care > Anesthesia</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p>This patient is hemodynamically unstable (ie, hypotensive, tachycardic).&nbsp; Prior to operative intervention, anesthesia must be induced.&nbsp; Three medications are commonly used because of their rapid onset of action and short duration of effect:</p><ul><li><strong>Propofol:</strong>&nbsp; A highly lipophilic GABA agonist that has the advantage of reducing airway resistance.&nbsp; Disadvantages include <strong>vasodilation</strong>, which can result in hypotension and an increase in serum triglycerides and lipase <strong>(Choice B)</strong>.</li></ul><ul><li><strong>Etomidate:</strong>&nbsp; A GABA agonist that has the advantage of being the most <strong>hemodynamically neutral</strong>.&nbsp; It does not cause changes in heart rate, blood pressure, or cardiac output.&nbsp; However, it inhibits cortisol synthesis, which can lead to <strong>adrenocortical suppression</strong> that is typically reversible.&nbsp; Because of this, etomidate is often avoided in patients with septic shock, and it should not be used as maintenance of sedation after induction <strong>(Choices C and E)</strong>.</li></ul><ul><li><strong>Ketamine:</strong>&nbsp; An N-methyl-d-aspartate antagonist that is similar to PCP, it preserves the respiratory drive during induction of anesthesia.&nbsp; Ketamine also provides an <strong>analgesic effect</strong>.&nbsp; It stimulates the release of catecholamines, which can cause <strong>bronchodilation</strong> but also increase heart rate, myocardial contractility, and cerebral blood flow.</li></ul><p>In <strong>hypotensive patients</strong>, anesthesia is often induced with either a hemodynamically neutral agent (<strong>etomidate</strong>) or one that may improve hemodynamics due to catecholamine release (<strong>ketamine</strong>).</p><p><strong>(Choice A)</strong>&nbsp; In contrast to ketamine, neither propofol nor etomidate provide an analgesic effect.</p><p><strong>Educational objective:</strong><br>Etomidate, a GABA agonist, is often used for anesthesia induction to provide sedation and amnesia.&nbsp; It is hemodynamically neutral, but it can result in transient adrenocortical suppression because it inhibits cortisol synthesis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "17280",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 65-year-old man comes to the emergency department due to worsening dyspnea.&nbsp; The patient has a history of cigarette smoking and chronic productive cough.&nbsp; He experienced increasing shortness of breath today without fever, chills, or chest pain.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 135/85 mm Hg, pulse is 94/min, and respirations are 24/min.&nbsp; Pulse oximetry shows 86% on room air.&nbsp; He has decreased breath sounds over the right chest.&nbsp; Chest x-ray is shown in the <a href=\"6958\">exhibit</a>.&nbsp; Which of the following is the most likely cause of this patient&#39;s radiographic findings?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Air leakage and accumulation in the right pleural space"
        },
        {
          "id": 2,
          "text": "Fibrous replacement of the pulmonary parenchyma"
        },
        {
          "id": 3,
          "text": "Fluid transudation into the interstitial and alveolar space"
        },
        {
          "id": 4,
          "text": "Occlusion of the right mainstem bronchus by mucus plug"
        },
        {
          "id": 5,
          "text": "Thromboembolic occlusion of the right pulmonary artery"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathology > Pulmonary & Critical Care > Atelectasis</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img  draggable=\"false\" id=\"6959\" src=\"https://www.uworld.com/media/highresdefault/L23442.png\"  ></p><p>This patient&#39;s right-sided decreased breath sounds and hemithorax opacification with tracheal deviation toward the opacified side are suggestive of <strong>right lung collapse</strong> (ie, atelectasis) due to obstruction of the <strong>right mainstem bronchus</strong>.&nbsp; This most commonly occurs due to <strong>mucus plugging</strong> in patients with chronic obstructive pulmonary disease or bronchiectasis, or due to <strong>malignant obstruction</strong> by a centrally located lung cancer (eg, squamous cell lung cancer).</p><p>Distal to the obstruction, air becomes trapped in the alveoli and gradually gets absorbed into the bloodstream, with ensuing large-volume alveolar collapse and pulling of the <strong>trachea&nbsp;toward the affected side</strong>.&nbsp; Other mediastinal structures (eg, heart, esophagus, great vessels) may also shift in the same direction.&nbsp; The loss of radiolucent air, combined with shifting of organs into the hemithorax, appears as a <strong>completely opacified hemithorax</strong> on chest x-ray.</p><p>In contrast, space-occupying pathology such as large <a href=\"443\">pleural effusion</a> or tension <a href=\"53008\">pneumothorax</a> (ie, air accumulation in the pleural space) forces tracheal deviation <em>away</em> from the affected side <strong>(Choice A)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Fibrous replacement of the pulmonary parenchyma occurs in <a href=\"539\">interstitial lung disease</a>.&nbsp; Chest x-ray is expected to show reticular markings in both lungs rather than complete opacification of one side.</p><p><strong>(Choice C)</strong>&nbsp; Fluid transudation into the alveoli and interstitial spaces occurs with <a href=\"33887\">pulmonary edema</a> (eg, heart failure).&nbsp; Chest x-ray typically shows bilateral fluffy-appearing infiltrates, often with an associated bilateral pleural effusion.&nbsp; However, the trachea remains midline.</p><p><strong>(Choice E)</strong>&nbsp; Thromboembolic occlusion of the right pulmonary artery (ie, acute pulmonary embolism) usually presents with a normal chest x-ray.&nbsp; Characteristic findings such as Westermark sign (area of distal arterial lucency due to the reduced perfusion) or Hampton hump (wedge-shaped opacity adjacent to the pleura) are only occasionally present.</p><p><strong>Educational objective:</strong><br>An obstructive lesion in a mainstem bronchus can prevent ventilation of an entire lung, leading to large-volume atelectasis and complete lung collapse.&nbsp; Characteristic findings on chest x-ray include unilateral opacification and deviation of the mediastinum toward the opacified lung.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "2116",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 32-year-old hospitalized man is evaluated for new-onset shortness of breath and confusion.&nbsp; The patient was admitted 3 days ago following a motor vehicle collision during which he sustained bilateral femur fractures, a pelvic fracture, and urethral injury.&nbsp; He underwent surgical repair with no operative complications.&nbsp; Temperature is 37.9 C (100.2 F), pulse is 110/min, respirations are 24/min, and oxygen saturation is 84% on room air.&nbsp; On physical examination, the patient appears agitated and disoriented.&nbsp; The lungs are clear to auscultation and there is no lower extremity edema.&nbsp; A petechial rash is present on the chest.&nbsp; ECG shows sinus tachycardia with no ischemic changes.&nbsp; Which of the following histologic changes has most likely taken place in this patient&#39;s lung tissue?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Alveolar fluid rich in neutrophils"
        },
        {
          "id": 2,
          "text": "Fat microglobules in pulmonary arterioles"
        },
        {
          "id": 3,
          "text": "Prominent interstitial infiltration by mononuclear cells"
        },
        {
          "id": 4,
          "text": "Red thrombus lodged in the pulmonary artery"
        },
        {
          "id": 5,
          "text": "Scattered necrosis with alveolar hemorrhage"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathology > Pulmonary & Critical Care > Fat embolism</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p>The clinical triad of acute-onset neurologic abnormalities, hypoxemia, and petechiae in a patient with traumatic bone fracture is strongly suggestive of <strong>fat embolism syndrome</strong> (FES).&nbsp; This condition most commonly occurs 24-72 hours following <strong>long-bone and/or pelvic fracture</strong>.&nbsp; Pathophysiologically, the traumatic event <strong>dislodges fat globules</strong> from the bone marrow and allows them to enter disrupted marrow venules, where they can then traverse the systemic veins and deposit in pulmonary microvessels.&nbsp; The <strong>pulmonary capillary occlusion </strong>impairs gas exchange and induces <strong>hypoxemia</strong>; release of free fatty acids from the fat globules also causes local toxic injury to the endothelium, potentially leading to acute respiratory distress syndrome.</p><p>Some fat globules escape the lungs via precapillary arteriovenous shunts that open due to increased pulmonary artery pressure.&nbsp; This phenomenon appears to be responsible for the fat emboli&ndash;associated microvascular occlusion that can occur within the CNS, manifesting with confusion and <strong>neurologic impairment</strong>, and in the dermal capillaries, resulting in erythrocyte extravasation and a <strong>petechial rash</strong>.</p><p><strong>(Choices A, C, and D)</strong>&nbsp; A neutrophil-rich alveolar exudate is not an early histologic manifestation of FES but rather of acute bacterial or aspiration pneumonia.&nbsp; Mononuclear interstitial pulmonary infiltrates are found early in the course of a variety of interstitial lung diseases.&nbsp; A red thrombus lodged in the pulmonary artery is consistent with a thromboembolism from a deep venous source.&nbsp; None of these conditions would typically be associated with the neurologic impairment or petechial rash seen with FES.</p><p><strong>(Choice E)</strong>&nbsp; Focal necrosis of alveolar walls with associated intra-alveolar hemorrhage is often seen with pulmonary hemorrhage syndromes (eg, anti-glomerular basement membrane antibody disease, granulomatosis with polyangiitis).</p><p><strong>Educational objective:</strong><br>Fat embolism syndrome should be strongly suspected in a patient with severe long-bone and/or pelvic fractures who develops acute-onset neurologic abnormalities, hypoxemia, and a petechial rash.&nbsp; Occlusion of the pulmonary microvessels by fat globules is an early histologic finding of this syndrome.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "1876",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 24-year-old man comes to the office due to nonproductive cough, subjective fevers, right-sided pleuritic chest pain, and increasing dyspnea for the past 4 weeks.&nbsp; He was empirically treated for pneumonia with levofloxacin at an urgent care center 2 weeks ago but has had no improvement.&nbsp; The patient is an exchange student from the Philippines.&nbsp; Temperature is 37.3 C (99.1 F), blood pressure is 118/66 mm Hg, pulse is 90/min, and respirations are 20/min.&nbsp; Physical examination is remarkable for decreased right-sided breath sounds.&nbsp; Chest x-ray shows a large, right-sided pleural effusion.&nbsp; Pleural fluid is drained, and a subsequent chest CT scan reveals right upper lobe infiltrate and calcified hilar adenopathy.&nbsp; This patient&#39;s pleural fluid analysis is most likely to demonstrate which of the following findings?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Cytology positive for atypical cells"
        },
        {
          "id": 2,
          "text": "Elevated fluid triglyceride level"
        },
        {
          "id": 3,
          "text": "Fluid protein concentration &gt;4.0 g/dL"
        },
        {
          "id": 4,
          "text": "Normal lactate dehydrogenase level"
        },
        {
          "id": 5,
          "text": "Predominant neutrophilic leukocytosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathophysiology > Pulmonary & Critical Care > Pleural effusion</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><div id=\"div_t43194\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Exudative &amp; transudative pleural effusions</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Exudate</strong></p></td><td><p align=\"center\"><strong>Transudate</strong></p></td></tr><tr><td><p align=\"center\"><strong>Light criteria</strong></p></td><td><p align=\"center\">Pleural protein/serum protein &gt;0.5<br /><strong>OR</strong><br />Pleural LDH/serum LDH &gt;0.6</p><p align=\"center\"><strong>OR</strong><br />Pleural LDH greater than two-thirds upper limit of normal of serum LDH</p></td><td><p align=\"center\">Exudate criteria not met</p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><p align=\"center\">Inflammatory increase<br />in membrane permeability</p></td><td><p align=\"center\">Change in hydrostatic or oncotic pressure</p></td></tr><tr><td><p align=\"center\"><strong>Common causes</strong></p></td><td><ul><li>Infection (eg, pneumonia, TB)</li><li>Malignancy</li><li>Rheumatologic disease</li></ul></td><td><ul><li>Heart failure</li><li>Cirrhosis (hepatic hydrothorax)</li><li>Nephrotic syndrome</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>LDH</strong> = lactate dehydrogenase; <strong>TB</strong> = tuberculosis.</p></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div><p>This patient&#39;s clinical findings are consistent with <strong>reactivation tuberculosis</strong>, given his nonresponse to routine pneumonia treatment, prior residence in an endemic region (ie, Southeast Asia), and CT scan showing calcified hilar adenopathy (representing granulomatous lymph node involvement).&nbsp; Reactivation tuberculosis typically affects the upper lobes of the lungs and is often associated with <strong>pleural effusion</strong>.</p><p>Pulmonary infection causes <a href=\"22505\">pleural effusion</a> primarily via an <strong>inflammatory</strong> increase in vascular and pleural membrane permeability, leading to relatively <strong>high pleural fluid protein and lactate dehydrogenase (LDH)</strong> concentration <strong>(Choice D)</strong>.&nbsp; Such effusions are <strong>exudative</strong> by Light criteria, with pleural fluid/serum protein ratio &gt;0.5, pleural fluid/serum LDH ratio &gt;0.6, and/or pleural fluid LDH &gt;&#8532; the upper limit of normal serum LDH.&nbsp; Normal serum total protein ranges from 6.0 g/dL to 7.8 g/dL; therefore, <strong>pleural fluid protein &gt;4 g/dL</strong> (ratio &gt;0.5) is most likely in this patient.</p><p><strong>(Choice A)</strong>&nbsp; Pleural fluid cytology showing atypical cells can be seen with a malignant pleural effusion, but is not expected with tuberculous effusion.&nbsp; Malignant effusions are also typically exudative by Light criteria.</p><p><strong>(Choice B)</strong>&nbsp; An elevated pleural fluid triglyceride level is diagnostic of a chylothorax, which results from disruption (eg, trauma, malignant invasion) of the thoracic duct leading to leakage of chylomicron-rich lymphatic fluid into the pleural space.</p><p><strong>(Choice E)</strong>&nbsp; Tuberculosis pleural effusions are typically lymphocyte predominant.&nbsp; Neutrophil predominance is expected with a typical parapneumonic effusion (eg, due to community-acquired bacterial pneumonia).</p><p><strong>Educational objective:</strong><br>Pulmonary infection (eg, community-acquired pneumonia, tuberculosis) causes pleural effusion primarily via an inflammatory increase in vascular and pleural membrane permeability.&nbsp; Such effusions are exudative by Light criteria, typically with relatively high pleural fluid protein and lactate dehydrogenase concentrations.&nbsp; Tuberculosis pleural effusions typically demonstrate a lymphocyte-predominant leukocyte pattern.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "18701",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 54-year-old woman comes to the office due to worsening nonproductive cough and dyspnea for the past several months.&nbsp; She also reports anorexia and&nbsp;an unintentional weight loss of 7 kg (15.4 lb).&nbsp; The patient has no prior medical conditions, takes no medications, and is a lifelong nonsmoker.&nbsp; Physical examination shows decreased breath sounds on the left side.&nbsp; Chest x-ray reveals a large left-sided pleural effusion.&nbsp; Thoracentesis yields fluid with a large number of red blood cells and numerous atypical cells staining positive for mucin.&nbsp; Which of the following is the most likely primary mechanism of this patient&#39;s pleural effusion?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Decreased plasma oncotic pressure"
        },
        {
          "id": 2,
          "text": "Disruption of the thoracic lymphatic duct"
        },
        {
          "id": 3,
          "text": "Increased intercostal venous pressure"
        },
        {
          "id": 4,
          "text": "Increased pulmonary capillary pressure"
        },
        {
          "id": 5,
          "text": "Occlusion of pleural lymphatic stoma"
        }
      ],
      "correct_choice_id": 5,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Physiology > Pulmonary & Critical Care > Pleural effusion</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img draggable=\"false\" id=\"22505\" src=\"https://www.uworld.com/media/L48965.jpg\" ></p><p>This patient&#39;s several-month history of nonproductive cough, shortness of breath, and weight loss combined with a large left-sided pleural effusion on chest x-ray raises suspicion for malignancy.&nbsp; Thoracentesis yielding a high erythrocyte concentration (a common finding in malignant effusions) and <strong>atypical mucin cells</strong> is consistent with <strong>adenocarcinoma</strong>; lung adenocarcinoma and breast adenocarcinoma are 2 of the most common causes of <strong>malignant pleural effusion</strong>.</p><p>Malignant effusions are <strong>exudative</strong> by <a href=\"18479\">Light criteria</a> and can occur via several mechanisms:</p><ul><li><p>Localized lung inflammation can cause <strong>increased vascular permeability</strong>, resulting in <strong>increased inflow of fluid</strong> into the pleural space.</p></li><li><p>Once malignant cells have metastasized to the pleural space, they can <strong>occlude the pleural lymphatic stoma</strong> located on the parietal surface and <strong>prevent pleural fluid reabsorption</strong>.&nbsp; This is likely the primary mechanism of effusion in this patient with evidence of pleural metastasis (ie, atypical mucin cells in pleural fluid).</p></li><li><p>Disruption of the thoracic lymphatic duct is an occasional cause of malignant effusion that leads to a chylothorax (milky white pleural fluid with high triglyceride content).&nbsp; This mechanism is most commonly seen with lymphoma; it can sometimes occur due to mass effect of lung cancer on the thoracic duct, but this is relatively uncommon <strong>(Choice B)</strong>.</p></li></ul><p><strong>(Choice A)</strong>&nbsp; Decreased plasma oncotic pressure (ie, hypoalbuminemia) is a common cause of transudative pleural effusion.&nbsp; Although hypoalbuminemia due to malnutrition may complicate malignancy and could contribute to pleural effusion, it is unlikely to be the primary mechanism in this patient with evidence of pleural metastatic disease.</p><p><strong>(Choices C and D)</strong>&nbsp; Increased hydrostatic pressure in the pulmonary capillaries and intercostal veins can cause transudative pleural effusion in patients with decompensated heart failure or other causes of intravascular volume overload (eg, renal failure).</p><p><strong>Educational objective:</strong><br>Malignant pleural effusions are usually exudative by Light criteria and can occur via several mechanisms, including an inflammation-induced increase in vascular permeability (leading to increased inflow) and blockage of pleural fluid reabsorption by parietal pleura lymphatics (leading to decreased outflow).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "18700",
      "difficulty": "N/A"
    },
    {
      "text": "<p>An 18-year-old, previously healthy man comes to the emergency department after being stabbed in the chest.&nbsp; The patient reports shortness of breath.&nbsp; Blood pressure is 136/84 mm Hg, pulse is 96/min, and respirations are 20/min.&nbsp; Oxygen saturation is 96%.&nbsp; Physical examination reveals a 2.5-cm stab wound on the right lateral chest wall.&nbsp; Breath sounds are decreased on the right side.&nbsp; Chest x-ray is shown in the <a href=\"38240\">exhibit</a>.&nbsp; Which of the following changes have most likely occurred in this patient&#39;s right hemithorax and right lung compared to his preinjury state?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Decreased\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased"
        },
        {
          "id": 2,
          "text": "Decreased\n\t\t\t\n\t\t\t\n\t\t\t\tNo change"
        },
        {
          "id": 3,
          "text": "Increased\n\t\t\t\n\t\t\t\n\t\t\t\tDecreased"
        },
        {
          "id": 4,
          "text": "No change\n\t\t\t\n\t\t\t\n\t\t\t\tDecreased"
        },
        {
          "id": 5,
          "text": "No change\n\t\t\t\n\t\t\t\n\t\t\t\tIncreased"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathophysiology > Pulmonary & Critical Care > Pneumothorax</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img draggable=\"false\" id=\"38241\" src=\"https://www.uworld.com/media/L63705.jpg\" ></p><p>This patient&#39;s <a href=\"26732\">chest x-ray</a> shows no peripheral lung markings on the right side and a tissue mass representing the collapsed right lung, findings consistent with <strong>pneumothorax</strong>; the stab wound likely breached the chest wall&nbsp;and pleura, allowing air to enter the intrapleural space.</p><p>The <strong>lungs exert collapsing force</strong> at all lung volumes, and the <strong>chest wall exerts expanding force</strong> at all but very high lung volumes.&nbsp; In the normal respiratory system, the lung and chest wall are in equilibrium (represented by the blue dot) at the functional residual capacity (FRC), and they move in concert throughout the respiratory cycle with the opposing forces working together to <strong>maintain negative intrapleural pressure</strong>.</p><p>When an abnormal communication pathway is created between the lung (or exterior chest) and the intrapleural space, intrapleural pressure <a href=\"36064,36065\">equalizes</a> with alveolar (ie, atmospheric) pressure, resulting in&nbsp;<strong>loss of intrapleural negative pressure</strong>.&nbsp; With the lung and chest wall no longer pulling each other in opposite directions, the chest wall springs outward to its equilibrium position (red dot),&nbsp;<strong>increasing&nbsp;hemithorax volume</strong>.</p><p>Loss of negative intrapleural pressure also causes the <strong>lung to collapse</strong> toward its equilibrium position (black dot).&nbsp; Compliance is defined as change in volume per change in pressure and is represented by the slope of the pressure-volume curve (eg, high compliance is illustrated by a steep-sloping curve).&nbsp; Lung compliance demonstrates hysteresis (ie, compliance differs during inspiration and expiration)&nbsp;due to the effects of alveolar surface tension.&nbsp; The flatness of the <strong>inspiratory lung compliance</strong> curve at very low lung volumes reflects the difficulty in inflating a collapsed lung and represents <strong>decreased </strong>compliance compared to that at the FRC.</p><p><strong>Educational objective:</strong><br>The lungs exert collapsing force, and the resting chest wall exerts expanding force.&nbsp; These opposing forces are in equilibrium at the functional residual capacity and generate sustained intrapleural negative pressure that allows the lung and chest wall to move together as a combined respiratory unit.&nbsp; Loss of intrapleural negative pressure (eg, pneumothorax) disrupts the combined system, causing the chest wall to spring outward to its equilibrium position, enlarging the hemithorax.&nbsp; Similarly, the lung collapses to its equilibrium position where inspiratory compliance is decreased.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "18448",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 31-year-old man comes to the office due to progressive dyspnea over the past several months.&nbsp; The patient states that the shortness of breath improved initially with supine positioning, but lately, it is present even on recumbency and during minimal exertion.&nbsp; He reports recurrent episodes of nosebleeds since childhood but has no other medical conditions.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/50 mm Hg, pulse is 102/min, and respirations are 20/min.&nbsp; Oxygen saturation is 96% on room air.&nbsp; Cardiac examination reveals an accentuated S2 over the upper left sternal border.&nbsp; The lungs are clear to auscultation.&nbsp; There is digital clubbing.&nbsp; Skin examination findings are shown in the <a href=\"24828\">exhibit</a>.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s dyspnea?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Airway obstruction"
        },
        {
          "id": 2,
          "text": "Endocardial infection"
        },
        {
          "id": 3,
          "text": "Pulmonary fibrosis"
        },
        {
          "id": 4,
          "text": "Valvular dysfunction"
        },
        {
          "id": 5,
          "text": "Vascular malformation"
        }
      ],
      "correct_choice_id": 5,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathophysiology > Pulmonary & Critical Care > Av malformation</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><div id=\"div_t66234\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hereditary hemorrhagic telangiectasia<br />(Rendu-Osler-Weber syndrome)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Autosomal dominant mutations impairing TGF-&beta; signaling</li><li>Disrupted angiogenesis &amp; loss of vascular integrity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mucocutaneous (oral, skin) telangiectasia</li><li>Recurrent epistaxis</li><li>Visceral organ AVMs: gastrointestinal tract (bleeding), lung (hemoptysis), brain (hemorrhagic stroke), liver</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>High-output heart failure*</li><li>Pulmonary hypertension*</li><li>Paradoxic embolism**</li><li>Iron deficiency anemia</li></ul></td></tr><tr><td colspan=\"2\"><p>*Secondary to high-volume, systemic AVMs.</p><p>**Bacterial translocation or embolization through pulmonary AVMs.</p><p><strong>AVMs</strong> = arteriovenous malformations; <strong>TGF-&beta;</strong> = transforming growth factor-&beta;.</p></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div><p>This young adult has a history of recurrent epistaxis, <a href=\"41390\">cutaneous telangiectasias</a>, and signs of pulmonary vascular disease.&nbsp; These findings are consistent with <strong>hereditary hemorrhagic telangiectasia</strong> (HHT) (Rendu-Osler-Weber syndrome).&nbsp; HHT is caused by autosomal dominant mutations of genes involved in angiogenesis (eg, <em>ENG</em>, <em>ACVRL1</em>), leading to multiorgan <strong>arteriovenous malformations</strong> (AVMs).&nbsp; In the lungs, HHT is associated with <strong>pulmonary AVMs</strong>, which may present with cyanosis, digital clubbing, hemoptysis, and <strong>platypnea</strong> (dyspnea aggravated by upright posture).&nbsp; The mechanism of platypnea is a gravitational increase in perfusion through the arteriovenous (AV) communications in the lower lung, worsening V/Q mismatch.</p><p>HHT can induce <strong>pulmonary hypertension</strong> (progressive dyspnea, loud P2 [pulmonic component of S2]) in some patients.&nbsp; This is usually due to extensive <strong>systemic AVMs</strong> (eg, hepatic) provoking <strong>chronic, high-output heart failure</strong> (widened pulse pressure, tachycardia) that elevates mean pulmonary arterial pressure.&nbsp; HHT vascular gene mutations can also induce hypertrophic remodeling, leading to occlusion of the small precapillary pulmonary arteries, contributing to development of pulmonary hypertension.</p><p><strong>(Choice A)</strong>&nbsp; Obstructive airway disease (eg, cystic fibrosis, bronchiectasis) may cause digital clubbing and a loud P2 (pulmonary hypertension due to lung disease).&nbsp; However, lung examination would be abnormal (eg, wheezing, decreased air movement).&nbsp; Furthermore, this patient&#39;s recurrent epistaxis, cutaneous angiomas, and platypnea are more suggestive of HHT.</p><p><strong>(Choices B and D)</strong>&nbsp; Infective endocarditis may cause digital clubbing and cutaneous lesions.&nbsp; Dermal findings include <a href=\"60625\">Osler nodes</a>, <a href=\"60626\">Janeway lesions</a>, and <a href=\"33959\">splinter hemorrhages</a>.&nbsp; Involvement of the aortic valve can cause aortic regurgitation, resulting in widened pulse pressure and heart failure.&nbsp; However, recurrent epistaxis, telangiectasias, and platypnea are more consistent with HHT.</p><p><strong>(Choice C)</strong>&nbsp; Pulmonary fibrosis can cause progressive dyspnea, digital clubbing, and a loud P2 (pulmonary hypertension due to lung disease).&nbsp; However, idiopathic pulmonary fibrosis affects individuals in late adulthood, and lung examination would reveal inspiratory crackles.</p><p><strong>Educational objective:</strong><br>Hereditary hemorrhagic telangiectasia presents with mucocutaneous telangiectasias, epistaxis, and visceral arteriovenous malformations (AVMs) (eg, liver, lung, brain).&nbsp; Lung involvement includes pulmonary AVMs (eg, digital clubbing, platypnea) and pulmonary hypertension (eg, a loud P2) due to high-output heart failure from underlying systemic AVMs.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "18341",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 46-year-old man comes to the emergency department due to shortness of breath, cough, and fever.&nbsp; The patient began experiencing mild upper respiratory illness a week ago.&nbsp; He has a history of asthma and was using inhaled bronchodilators more frequently since the onset of respiratory illness.&nbsp; Over the past 2 days, he has had worsening breathlessness, productive cough, and high fever.&nbsp; The patient has no other medical conditions.&nbsp; Temperature is 38.9 C (102 F), blood pressure is 90/60 mm Hg, pulse is 120/min, and respirations are 28/min.&nbsp; On physical examination, the patient appears in severe respiratory distress with intercostal retractions.&nbsp; Lung auscultation reveals bilateral wheezing.&nbsp; Prompt endotracheal intubation for respiratory support is planned.&nbsp; Prior to endotracheal intubation, intravenous ketamine is administered for induction of anesthesia.&nbsp; Which of the following characteristics is the most likely reason for use of this anesthetic agent in this patient?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Direct GABA agonism"
        },
        {
          "id": 2,
          "text": "Lower lipid solubility"
        },
        {
          "id": 3,
          "text": "Metabolism by plasma enzymes"
        },
        {
          "id": 4,
          "text": "Neuromuscular blockade effect"
        },
        {
          "id": 5,
          "text": "Sympathomimetic activity"
        }
      ],
      "correct_choice_id": 5,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pharmacology > Pulmonary & Critical Care > Anesthesia</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p>This hemodynamically unstable patient has severe <strong>bronchospasm</strong> and impending respiratory failure and requires intubation.&nbsp; Prior to intubation, anesthesia must be induced.&nbsp; Three medications are commonly used because of their rapid onset of action and short duration of effect.</p><ul><li><strong>Propofol:</strong> A highly lipophilic GABA agonist that may be used for <strong>long-term sedation</strong>.&nbsp; Disadvantages include vasodilation, which can result in <strong>hypotension</strong> and an increase in serum triglycerides and lipase.</li></ul><ul><li><strong>Etomidate:</strong> A GABA agonist that has the advantage of being the most <strong>hemodynamically neutral</strong>.&nbsp; It does not cause changes in heart rate, blood pressure, or cardiac output.&nbsp; However, it inhibits cortisol synthesis, which can lead to (reversible) <strong>adrenocortical suppression</strong>.&nbsp; Because of this, it is often avoided in patients with septic shock, and it should not be used as maintenance of sedation after induction.</li></ul><ul><li><strong>Ketamine:</strong> An N-methyl-D-aspartate (NMDA) antagonist&nbsp;that is similar to PCP; it <strong>preserves the respiratory drive</strong> during induction of anesthesia.&nbsp; In contrast to propofol and etomidate, it also provides an analgesic effect.&nbsp; Ketamine stimulates the release of catecholamines (ie, <strong>sympathomimetic</strong>), which can cause <strong>bronchodilation</strong> but also increase the heart rate, myocardial contractility, and cerebral blood flow, potentially putting the patient at risk for cardiovascular events or increased intracranial pressure.</li></ul><p>In this patient with an acute asthma attack, <strong>ketamine </strong>was likely chosen because it stimulates release of catecholamines that increase sympathomimetic activity and may <strong>improve bronchospasm</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Propofol and etomidate are both GABA agonists, but ketamine works at the NMDA receptor.</p><p><strong>(Choice B)</strong>&nbsp; Both ketamine and etomidate are much less lipophilic than propofol.</p><p><strong>(Choice C)</strong>&nbsp; Both ketamine and etomidate are metabolized primarily by the liver.&nbsp; Propofol is also metabolized by the liver, but the effect is terminated by its redistribution rather than metabolism.</p><p><strong>(Choice D)</strong>&nbsp; Neuromuscular blockade is often used to facilitate intubation.&nbsp; None of the three commonly used induction anesthetics cause significant neuromuscular blockade, so an additional medication (eg, succinylcholine, rocuronium) is used if needed.</p><p><strong>Educational objective:</strong><br>Ketamine can be used for anesthesia induction.&nbsp; The side effects of increased catecholamine release (eg, bronchodilation) are often exploited in patients with bronchospasm.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "17279",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 72-year-old woman is brought to the emergency department due to exertional chest pain.&nbsp; The patient is on vacation with her family and her symptoms began after arriving in the Colorado mountains.&nbsp; She has a history of coronary artery disease but has had no ischemic symptoms over the past several years.&nbsp; The patient is a lifetime nonsmoker and has no history of lung disease.&nbsp; Physical examination shows mild hypoxemia, clear lungs, an S4, and no extremity edema.&nbsp; ECG shows T-wave inversion in the lateral leads.&nbsp; Serum troponin and D-dimer levels are within normal limits.&nbsp; It is determined that decreased oxygen levels at high altitude in combination with an age-related decline in pulmonary function resulted in exacerbation of this patient&#39;s preexisting heart disease.&nbsp; Which of the following most likely contributed to this patient&#39;s current condition?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Decreased chest wall mobility"
        },
        {
          "id": 2,
          "text": "Decreased dead space ventilation"
        },
        {
          "id": 3,
          "text": "Increased chemoreceptor responsiveness"
        },
        {
          "id": 4,
          "text": "Increased forced vital capacity"
        },
        {
          "id": 5,
          "text": "Increased lung elastic recoil"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathophysiology > Pulmonary & Critical Care > Aging</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p>The reduced partial pressure of inspired oxygen at high altitude leads to <strong>hypoxemia</strong> (ie, reduced partial pressure of arterial oxygen [PaO<font size=\"2\"><sub>2</sub></font>]).&nbsp; <strong>Hyperventilation</strong> is the most immediate and important physiologic adjustment to high altitude; peripheral chemoreceptors stimulate increased minute ventilation (via both increased tidal volume and respiratory rate) to help increase PaO<font size=\"2\"><sub>2</sub></font> and minimize the symptoms of hypoxemia (eg, headache, dyspnea).</p><p>In older individuals (eg, <strong>age &gt;65</strong>), the body is less able to compensate for the hypoxemia at high altitude due to a number of age-related changes to the respiratory system.&nbsp; These changes include the following:</p><ul><li><p><strong>Decreased chest wall compliance:</strong>&nbsp; Calcification of the intercostal joints and tendon insertion sites, as well as degeneration of the spine (eg, kyphosis), reduces chest wall expansion and limits the potential increase in tidal volume.</p></li><li><p><strong>Decreased alveolar elastic recoil</strong>:&nbsp; Degeneration of elastin causes increased alveolar compliance with alveolar enlargement and increased air trapping.&nbsp; This <a href=\"4667\">increases residual volume</a> and decreases forced vital capacity, further limiting the achievable increase in tidal volume <strong>(Choices D and E)</strong>.</p></li><li><p>Increased alveolar-arterial O<font size=\"2\"><sub>2</sub></font> gradient:&nbsp; The alveolar enlargement increases ventilation-perfusion mismatch and decreases the efficiency of O<font size=\"2\"><sub>2</sub></font> exchange in 2 ways.&nbsp; First, it decreases the percentage of alveolar surface area in contact with alveolar capillaries, effectively increasing <a href=\"22175\">dead space</a><strong> (Choice B)</strong>.&nbsp; Second, the increased air trapping decreases ventilation of highly perfused alveoli at the base of the lungs.</p></li></ul><p>In this elderly patient, the body&#39;s ability to maintain PaO<font size=\"2\"><sub>2</sub></font> at <strong>high altitude</strong> has likely been reduced, and, given her underlying coronary artery disease, she is likely experiencing <strong>angina</strong> (eg, exertional chest pain) due to inadequate O<font size=\"2\"><sub>2</sub></font> supply to the myocardium.</p><p><strong>(Choice C)</strong>&nbsp; Aging appears to have minimal effect on chemoreceptor responsiveness; therefore, respiratory drive is appropriately increased at high altitude.&nbsp; Age-related changes that reduce the mechanical efficiency of the respiratory system (ie, ability to respond to increased respiratory drive) are primarily responsible for reduced compensation for hypoxemia at high altitude.</p><p><strong>Educational objective:</strong><br>Age-related changes to the respiratory system include decreased chest wall compliance and decreased alveolar elastic recoil with resulting alveolar enlargement and air trapping.&nbsp; These changes limit the potential increase in tidal volume and also increase the alveolar-arterial O<font size=\"2\"><sub>2 </sub></font>gradient (ie, decrease the efficiency of alveolar-capillary gas exchange), reducing the ability to compensate for hypoxemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "17827",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 39-year-old woman comes to the office due to a nagging cough.&nbsp; Two weeks ago, the patient had a mild upper respiratory illness which resolved spontaneously after several days.&nbsp; Since then, she has had cough that is productive of minimal clear sputum.&nbsp; The patient has had no shortness of breath or chest pain.&nbsp; She took unexpired, leftover dextromethorphan for 2 days.&nbsp; The patient&#39;s only other medical condition is major depression, for which she takes sertraline.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Vital signs and physical examination show no abnormalities.&nbsp; Use of dextromethorphan is most concerning for which of the following in this patient?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Potential for recreational use"
        },
        {
          "id": 2,
          "text": "Drug-drug interaction"
        },
        {
          "id": 3,
          "text": "Liver injury"
        },
        {
          "id": 4,
          "text": "Hypoventilation"
        },
        {
          "id": 5,
          "text": "Rebound symptoms after discontinuation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pharmacology > Pulmonary & Critical Care > Chronic cough</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><div id=\"div_t66289\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Dextromethorphan</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mechanism<br />of action</strong></p></td><td><ul><li>Activates medullary sigma receptors &reg; cough suppressant</li><li>Trivial &delta;/&mu; opioid receptor agonism at therapeutic dose:<ul><li>No constipation</li><li>Minimal respiratory depression</li><li>No analgesic effect</li><li>Low abuse potential</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Overdose</strong></p></td><td><ul><li>Serotonin toxicity: hypertonia, autonomic instability, encephalopathy</li><li>NMDA receptor inhibition: hallucinations, dissociation</li><li>Respiratory depression and coma at very high doses</li></ul></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div><p><strong>Dextromethorphan</strong> (DXM) is a popular <strong>cough suppressant</strong> (antitussive agent) that is readily available over the counter.&nbsp; Its primary mechanism of action is inhibition of the medullary cough center through <strong>sigma (&#963;) receptor activation</strong>.&nbsp; Although structurally very closely related to other opioid morphinans (eg, codeine, morphine), DXM has trivial mu (&#956;) and delta (&#948;) opioid receptor affinity.&nbsp; Therefore, <strong>classic opioid adverse effects</strong> (eg, constipation, respiratory depression, analgesia, sedation) are <strong>not seen</strong> at therapeutic doses.&nbsp; This favorable pharmacologic profile makes DXM a first-choice agent for cough suppression.</p><p>However, DXM also increases serotonin activity in the CNS by decreasing the rate of presynaptic serotonin reuptake and directly stimulating serotonin receptors.&nbsp; For this reason, DXM abuse can cause <strong>serotonin syndrome</strong>, manifesting as muscular hypertonia, spasticity (eg, clonus, hyperreflexia), autonomic instability (eg, hyperthermia, hypertension), and encephalopathy.&nbsp; This potentially fatal condition most often occurs in settings of overdose or accidental <a href=\"44763\">drug interaction</a> with other serotonergic drugs (eg, selective serotonin reuptake inhibitors, triptans, monoamine oxidase inhibitors).</p><p><strong>(Choice A)</strong>&nbsp; Although DXM has the potential for abuse, addiction is less likely than with opioid cough suppressants (eg, codeine).&nbsp; Recreational drug use typically begins in peer settings, and adolescents and young adults are at greatest risk; this 39-year-old woman has no history of recreational drug use and is likely at low risk.</p><p><strong>(Choice C)</strong>&nbsp; DXM has no intrinsic hepatotoxicity.&nbsp; However, acute liver injury can occur in overdose scenarios involving combination dextromethorphan-acetaminophen preparations (eg, multi-symptom cold remedies).</p><p><strong>(Choice D)</strong>&nbsp; Although it has negligible &#956; receptor agonism at therapeutic doses, DXM at high doses may cause intoxication that can occasionally elicit enough &#956; receptor agonism to produce hypoventilation and stupor.&nbsp; These symptoms can be reversed with naloxone.</p><p><strong>(Choice E)</strong>&nbsp; Patients who use over-the-counter decongestants (eg, oxymetazoline or phenylephrine sprays, oral pseudoephedrine) for prolonged periods can develop rhinitis medicamentosa, characterized by rebound nasal congestion, rhinorrhea, and turbinate hypertrophy.&nbsp; However, rebound cough is not observed on DXM withdrawal.</p><p><strong>Educational objective:</strong><br>Dextromethorphan (DXM) is a popular over-the-counter antitussive agent that acts on sigma receptors to suppress the medullary cough center.&nbsp; DXM also has an off-target action on serotonin transports and receptors in the CNS.&nbsp; Overdose or accidental interaction with other serotonergic medications (eg, selective serotonin reuptake inhibitors, antidepressants) can precipitate serotonin syndrome.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "17217",
      "difficulty": "N/A"
    },
    {
      "text": "<p>Physiologists are studying the mechanisms of pleural fluid formation and absorption in the normal state.&nbsp; They obtain healthy experimental animals whose pleuropulmonary anatomy and physiology closely resembles that of humans.&nbsp; Intravenous radioisotope tracers are injected into these animals and are monitored closely to track fluid movement into and out of the pleural space.&nbsp; Which of the following pathways of pleural fluid turnover is most likely to be observed?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Bronchial microvessels\n\t\t\t\n\t\t\t\n\t\t\t\t&#8594;\n\t\t\t\n\t\t\t\n\t\t\t\tPulmonary capillaries"
        },
        {
          "id": 2,
          "text": "Bronchial microvessels\n\t\t\t\n\t\t\t\n\t\t\t\t&#8594;\n\t\t\t\n\t\t\t\n\t\t\t\tPulmonary parenchymal lymphatics"
        },
        {
          "id": 3,
          "text": "Intercostal microvessels\n\t\t\t\n\t\t\t\n\t\t\t\t&#8594;\n\t\t\t\n\t\t\t\n\t\t\t\tParietal pleural lymphatics"
        },
        {
          "id": 4,
          "text": "Intercostal microvessels\n\t\t\t\n\t\t\t\n\t\t\t\t&#8594;\n\t\t\t\n\t\t\t\n\t\t\t\tPulmonary capillaries"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Physiology > Pulmonary & Critical Care > Pleural effusion</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img draggable=\"false\" id=\"40781\" src=\"https://www.uworld.com/media/L66854.jpg\" ></p><p>Humans normally have approximately 5-10 mL of <strong>pleural fluid</strong> in the intrapleural space of each hemithorax, with inflow and outflow of fluid taking place at equal rates to maintain homeostasis.&nbsp; Pleural fluid is believed to <strong>enter</strong> the pleural space via filtration from <strong>systemic circulation</strong> in both the parietal and visceral pleura, with the majority of fluid filtered from the <strong>intercostal microvessels</strong> in the <strong>parietal pleura</strong> and a lesser amount from the bronchial microvessels in the visceral pleura.</p><p>Most pleural fluid likely <strong>exits</strong> the pleural space via holes in the parietal pleura known as lymphatic stoma that drain into the <strong>parietal pleural lymphatics</strong>.</p><p><a href=\"22505\">Pleural effusion</a> results from an increase in the rate of pleural fluid inflow (eg, increased fluid filtration as occurs with decompensated heart failure, hypoalbuminemia, or an inflammatory increase in pleural vascular permeability) or a decrease in the rate of pleural fluid outflow (eg, malignant obstruction of the parietal pleura lymphatic stoma).</p><p><strong>(Choices A, B, and D)</strong>&nbsp; Neither the pulmonary capillaries nor the pulmonary parenchymal lymphatics significantly contribute to the uptake of pleural fluid from the pleural space in the normal or pathologic state.&nbsp; Fluid from the pulmonary (alveolar) capillaries (ie, the pulmonary circulation) does not significantly contribute to inflow of pleural fluid into the pleural space in the normal state; however, it can become a primary source of fluid inflow in pathologic states (eg, increased pulmonary capillary hydrostatic pressure with decompensated heart failure).</p><p><strong>Educational objective:</strong><br>Pleural fluid normally enters the pleural space via filtration from the systemic circulation, primarily from the intercostal microvessels of the parietal pleura, and exits the pleural space via stomata in the parietal pleura that drain into the parietal pleura lymphatics.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "18702",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 38-year-old man comes to the office with reports of dyspnea on exertion and decreased exercise tolerance.&nbsp; His medical history is unremarkable, and he has no history of childhood asthma or cough.&nbsp; He has never smoked and has no known occupational exposures.&nbsp; The patient has gained almost 100 lb over the past 4 years since leaving the military due to a sedentary lifestyle.&nbsp; He currently weighs 135 kg (297.6 lb) and has a BMI of 41 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; His respiratory rate is 22/min and pulse oximetry is 93% on room air at rest.&nbsp; Physical examination is notable for central obesity.&nbsp; Lungs are clear on auscultation bilaterally.&nbsp; Which of the following changes (forced expiratory volume in 1 second [FEV<font size=\"2\"><sub>1</sub></font>], forced vital capacity [FVC], expiratory reserve volume [ERV], residual volume [RV], and total lung capacity [TLC]) are most likely to be seen on pulmonary function testing in this patient?</p>",
      "choices": [
        {
          "id": 1,
          "text": "&#8595;\n\t\t\t&#8595;\n\t\t\t&#8595;\n\t\t\tNormal\n\t\t\t&#8595;"
        },
        {
          "id": 2,
          "text": "&#8595;\n\t\t\t&#8595;\n\t\t\tNormal\n\t\t\t&#8593;\n\t\t\t&#8593;"
        },
        {
          "id": 3,
          "text": "&#8595;\n\t\t\tNormal\n\t\t\tNormal\n\t\t\t&#8593;\n\t\t\t&#8593;"
        },
        {
          "id": 4,
          "text": "&#8593;\n\t\t\t&#8593;\n\t\t\t&#8595;\n\t\t\tNormal\n\t\t\tNormal"
        },
        {
          "id": 5,
          "text": "&#8593;\n\t\t\tNormal\n\t\t\t&#8593;\n\t\t\t&#8593;\n\t\t\t&#8593;"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathophysiology > Pulmonary & Critical Care > Obesity</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img id=\"1156\"  src=\"https://www.uworld.com/media/L16332.jpg\"  draggable=\"false\" ></p><p>This young patient presenting with respiratory symptoms and <strong>central obesity</strong> without a history of pulmonary disease likely has obesity-related <strong>restrictive lung disease</strong>.&nbsp; Obesity alters respiratory compliance, which is the ability of the lung and chest wall to stretch in response to increased lung pressures.&nbsp; Respiratory compliance is diminished both by a reduction in chest wall compliance from increased weight and by a reduction in lung compliance due to microatelectasis.&nbsp; To compensate for the reduced compliance, obese patients typically have increased respiratory rates with reduced tidal volumes (rapid-shallow breathing).</p><p>The most common indicator of obesity-related disease is a <strong>reduction</strong> in <strong>expiratory reserve volume</strong> (ERV), which is the maximum volume of air that can be expired after a normal tidal expiration.&nbsp; Obesity has minimal effect on residual volume (RV), but <strong>functional residual capacity</strong>, which is the sum of RV and ERV, is reduced due to the marked reduction in ERV.&nbsp; Obesity can also cause reductions of forced vital capacity (FVC), forced expiratory volume in 1 second (FEV<font size=\"2\"><sub>1</sub></font>), and total lung capacity (TLC), depending on the severity of obesity and body fat distribution (abdominal obesity causes greater impairment).&nbsp; However, these reductions are generally modest, especially relative to decrements in ERV.</p><p><strong>(Choices B and C)</strong>&nbsp; These are patterns that may be seen in a patient with chronic obstructive pulmonary disease, with FEV<font size=\"2\"><sub>1</sub></font> reduced and FVC normal or only mildly diminished in comparison to FEV<font size=\"2\"><sub>1</sub></font>.&nbsp; TLC and RV are increased with emphysema.</p><p><strong>(Choices D and E)</strong>&nbsp; FEV<font size=\"2\"><sub>1</sub></font>, FVC, and TLC may be increased in trained athletes.</p><p><strong>Educational objective:</strong><br>Obesity, particularly morbid, central obesity, can cause a pattern of extrinsic restrictive pulmonary function tests.&nbsp; The most common indicator of obesity-related disease is a reduction in expiratory reserve volume and functional residual capacity, but forced expiratory volume in 1 second, forced vital capacity, and total lung capacity are also typically decreased.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "10772",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 65-year-old man comes to the office due to shortness of breath, weakness, and cough for 1 week.&nbsp; He underwent bilateral lung transplantation for idiopathic pulmonary fibrosis 3 months ago.&nbsp; Temperature is 38.3 C (101 F), blood pressure is 130/80 mm Hg, pulse is 90/min, and respirations are 18/min.&nbsp; Chest x-ray shows perihilar opacities and interstitial edema.&nbsp; Transbronchial biopsies reveal moderate perivascular and peribronchiolar mononuclear infiltrate predominantly composed of lymphocytes.&nbsp; No viral inclusions are present.&nbsp; Which of the following is the most likely diagnosis?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Left ventricular dysfunction"
        },
        {
          "id": 2,
          "text": "Pneumococcal pneumonia"
        },
        {
          "id": 3,
          "text": "Polyarteritis nodosa"
        },
        {
          "id": 4,
          "text": "Recurrence of primary lung disease"
        },
        {
          "id": 5,
          "text": "Transplant rejection"
        }
      ],
      "correct_choice_id": 5,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathology > Pulmonary & Critical Care > Lung transplantation</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><div id=\"div_T40843\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Lung transplant rejection</strong></p></td></tr><tr><td><p align=\"center\"><strong>Type</strong></p></td><td><p align=\"center\"><strong>Onset</strong></p></td><td><p align=\"center\"><strong>Etiology</strong></p></td><td><p align=\"center\"><strong>Pathophysiology</strong></p></td></tr><tr><td><p align=\"center\"><strong>Hyperacute</strong></p></td><td><p>Minutes to hours</p></td><td><p><strong>Preformed host antibodies</strong> to donor ABO or HLA</p></td><td><p>Neutrophilic infiltration with fibrinoid necrosis and thrombosis</p></td></tr><tr><td><p align=\"center\"><strong>Acute</strong></p></td><td><p>&#8804;6 months</p></td><td><p>Cell-mediated response to mismatched donor HLA</p></td><td><p>Perivascular (small lung vessels) &amp; submucosal (bronchiole) lymphocytic infiltrates</p></td></tr><tr><td><p align=\"center\"><strong>Chronic</strong></p></td><td><p>Months or years</p></td><td>Chronic, low-grade, mixed cell-mediated and antibody response to HLA antigens</td><td><p>Submucosal inflammation &#8594; granulation, scarring &amp; <strong>bronchiolitis obliterans</strong></p></td></tr><tr><td colspan=\"4\"><p><strong>HLA</strong> = human leukocyte antigen.</p></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div><p>This patient with dyspnea, cough, fever, and lung biopsy revealing lymphocytic infiltration several months after lung transplant likely has <strong>acute lung transplant rejection</strong>.&nbsp; Acute transplant rejection (ATR) is a <strong>cell-mediated response</strong> involving T-lymphocyte activation against donor antigens (eg, mismatched HLA types) and most commonly occurs <strong>within 6 months</strong> of transplant.</p><p>Patients with ATR may be asymptomatic (with rejection detected by surveillance biopsy) or can present with <strong>low-grade fever</strong>, dyspnea, <strong>cough</strong>, and/or fatigue.&nbsp; Chest x-ray may reveal hilar lymphatic enlargement and edematous interstitial thickening.&nbsp; Lung biopsy reveals <strong>perivascular and peribronchiolar mononuclear infiltrate</strong> primarily composed of <strong>lymphocytes</strong>.&nbsp; The <strong>absence of viral inclusions</strong> in epithelial cells helps rule out cytomegalovirus, a common infection in lung transplant recipients that can present similarly to acute rejection.</p><p>The risk of ATR markedly increases with poor adherence to immunosuppression medications (eg, tacrolimus, mycophenolate), but it can affect all transplant recipients, regardless of medication adherence.&nbsp; Episodes of ATR are usually reversible with increased immunosuppression (eg, high-dose steroids); however, patients with frequent episodes of ATR are at greater risk of developing chronic transplant rejection, which is typically irreversible.</p><p><strong>(Choice A)</strong>&nbsp; Left ventricular dysfunction can cause pulmonary edema with similar appearance to ATR on chest x-ray.&nbsp; However, fever is not expected, and lung biopsy typically reveals hemosiderin-laden macrophages with no evidence of inflammatory lymphocytic infiltrate.</p><p><strong>(Choice B)</strong>&nbsp; Lung transplant recipients are at increased risk of bacterial (eg, Pneumococcal) pneumonia; however, chest x-ray is more likely to reveal focal alveolar consolidation, and neutrophil predominance is expected on lung biopsy.</p><p><strong>(Choice C)</strong>&nbsp; Polyarteritis nodosa is a medium vessel vasculitis that typically demonstrates lymphocytic infiltrate with vascular wall necrosis on biopsy.&nbsp; It can affect multiple organs, including the liver, kidneys, intestines, and skin; however, it characteristically spares the lungs.</p><p><strong>(Choice D)</strong>&nbsp; Eventual recurrence of primary lung disease following lung transplantation is possible for many diseases (eg, interstitial lung disease, bronchiectasis) but is unlikely within only several months.</p><p><strong>Educational objective:</strong><br>Acute lung transplant rejection is a cell-mediated response involving T-lymphocyte activation against donor antigens and typically occurs within 6 months of transplant.&nbsp; Affected patients can have shortness of breath, cough, and low-grade fever.&nbsp; Lung biopsy reveals perivascular and peribronchiolar lymphocytic infiltrate and absence of epithelial cell viral inclusions (ruling out cytomegalovirus).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "17834",
      "difficulty": "N/A"
    }
  ]
}